Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02446184 · ClinicalTrials.gov registry record · NA
Fetal Cystoscopy for Lower Urinary Tract Obstruction
A NA study, sponsored by Baylor College of Medicine.
- Terminated
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT02446184: Clinical Trial NA study, sponsored by Baylor College of Medicine.
NCT02446184 is a NA study that was terminated before completion, run by Baylor College of Medicine. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02446184, a NA study, was terminated before completion, sponsored by Baylor College of Medicine.
- TERMINATED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
This is a pilot study to evaluate the safety, feasibility, and effectiveness of fetal cystoscopy as an experimental procedure in avoiding perinatal death and renal impairment and to compare to the investigators clinical experience with fetal vesicoamniotic shunting.
Primary Outcome
We will evaluate the survival rate at 2 years of life
Interventions
- PROCEDURE Fetal Cystoscopy
- PROCEDURE Fetal vesicoamniotic shunt
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2014-12-04 |
| Est. Completion | 2016-08-23 |
| Phase | NA |
Why NCT02446184 stopped before completion
NCT02446184 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Fetal Cystoscopy is the first listed.
NCT02446184 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02446184 about?
NCT02446184 is a clinical study titled "Fetal Cystoscopy for Lower Urinary Tract Obstruction". This is a pilot study to evaluate the safety, feasibility, and effectiveness of fetal cystoscopy as an experimental procedure in avoiding perinatal death and renal impairment and to compare to the investigators clinical experience with fetal vesicoamniotic shunting.
What is the current status of trial NCT02446184?
This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2014-12-04. Estimated completion is 2016-08-23.
What interventions are being tested in trial NCT02446184?
The interventions under investigation include: Fetal Cystoscopy (PROCEDURE), Fetal vesicoamniotic shunt (PROCEDURE).
Who is sponsoring clinical trial NCT02446184?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02446184's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI